Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-21 09:00 am Purchase |
2025-02-20 | 13D | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 13,307,967 7.000% |
440,000 (+3.42%) |
Filing History |
| 2025-01-24 4:40 pm Purchase |
2025-01-21 | 13G | INNOVATE Corp. VATE |
Whitefort Capital Management, LP | 1,029,264 7.600% |
1,029,264 (New Position) |
Filing History |
| 2024-12-06 6:52 pm Sale |
2024-11-05 | 13G | Cadiz Inc. CDZI |
Whitefort Capital Management, LP | 3,755,192 4.990% |
-1,605,398 (-29.95%) |
Filing History |
| 2024-11-14 4:13 pm Sale |
2024-09-30 | 13G | Global Ship Lease, Inc. GSL |
Whitefort Capital Management, LP | 366,771 1.000% |
-1,530,710 (-80.67%) |
Filing History |
| 2024-11-12 4:50 pm Purchase |
2024-11-05 | 13G | Cadiz Inc. CDZI |
Whitefort Capital Management, LP | 5,360,590 7.000% |
5,360,590 (New Position) |
Filing History |
| 2024-05-17 09:03 am Unchanged |
2024-05-17 | 13D | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 12,867,967 6.800% |
0 (Unchanged) |
Filing History |
| 2024-05-09 08:00 am Sale |
2024-05-02 | 13D | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 12,867,967 6.800% |
-329,095 (-2.49%) |
Filing History |
| 2024-02-14 4:38 pm Purchase |
2023-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 13,197,062 7.900% |
3,183,163 (+31.79%) |
Filing History |
| 2024-02-14 4:37 pm Sale |
2023-12-31 | 13G | The Central and Eastern Europe Fund, Inc. CEE |
Whitefort Capital Management, LP | 305,015 4.800% |
-244,985 (-44.54%) |
Filing History |
| 2024-02-14 4:35 pm Sale |
2023-12-31 | 13G | Global Ship Lease, Inc. GSL |
Whitefort Capital Management, LP | 1,897,481 5.400% |
-79,807 (-4.04%) |
Filing History |
| 2023-09-11 5:07 pm Purchase |
2023-09-01 | 13G | Arbutus Biopharma Corporation ABUS |
Whitefort Capital Management, LP | 10,013,899 6.000% |
10,013,899 (New Position) |
Filing History |
| 2023-02-14 3:05 pm Purchase |
2022-12-31 | 13G | Global Ship Lease, Inc. GSL |
Whitefort Capital Management, LP | 1,977,288 5.500% |
81,000 (+4.27%) |
Filing History |
| 2022-12-16 4:04 pm Purchase |
2022-12-07 | 13G | Global Ship Lease, Inc. GSL |
Whitefort Capital Management, LP | 1,896,288 5.200% |
1,896,288 (New Position) |
Filing History |
| 2022-11-10 4:09 pm Purchase |
2022-10-31 | 13G | The Central and Eastern Europe Fund, Inc. CEE |
Whitefort Capital Management, LP | 550,000 8.800% |
550,000 (New Position) |
Filing History |